Chromosome 6 suffers frequent and multiple aberrations in thymoma

American Journal of Pathology

Volumn 161, Issue 4, 2002, Pages 1507-1513

  Inoue, Masayoshi ^a   Marx, Alexander ^a   Zettl, Andreas ^a   Ströbel, Philipp ^a   Müller Hermelink, Hans Konrad ^a   Starostik, Petr ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 6; CHROMOSOME 6Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME MAP; CONTROLLED STUDY; DNA FLANKING REGION; GENE LOCATION; GENE LOCUS; GENETIC MARKER; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSATELLITE INSTABILITY; PATHOGENESIS; PRIORITY JOURNAL; THYMOMA; TUMOR SUPPRESSOR GENE;

EID: 0036792519     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64426-4     Document Type: Article

References (44)

1. Willcox N: Myasthenia gravis. Curr Opin Immunol 1993, 5:910-917
2. Müller-Hermelink HK, Marx A: Thymoma. Curr Opin Oncol 2000, 12:426-433
3. Kristoffersson U, Heim S, Mandahl N, Akerman M, Mitelman F: Multiple clonal chromosome aberrations in two thymomas. Cancer Genet Cytogenet 1989, 41:93-98
4. Sonobe H, Takeuchi T, Ohtsuki Y, Taguchi T, Shimizu K: A thymoma with clonal complex chromosome abnormalities. Cancer Genet Cytogenet 1999, 110:72-74
5. Mirza I, Kazimi SN, Ligi R, Burns J, Braza F: Cytogenetic profile of a thymoma. A case report and review of the literature. Arch Pathol Lab Med 2000, 124:1714-1716
6. Kees UR, Mulcahy MT, Willoughby MLN: Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19). Am J Pediatr Hematol Oncol 1991, 13:459-464
7. Kubonishi I, Takehara N, Iwata J, Sonobe H, Ohtsuki Y, Abe T, Miyoshi I: Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res 1991, 51:3327-3328
8. Lee ACW, Kwong Y-L, Fu KH, Chan GCF, Ma L, Lau Y-L: Disseminated mediastinal carcinoma with chromosomal translocation (15;19). A distinctive clinicopathologic syndrome. Cancer 1993, 72:2273-2276
9. Zettl A, Ströbel P, Wagner K, Katzenberger T, Ott G, Rosenwald A, Peters K, Krein A, Semik M, Müller-Hermelink HK, Marx A: Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol 2000, 157:257-266
10. Zhou R, Zettl A, Ströbel P, Wagner K, Müller-Hermelink HK, Zhang S, Marx A, Starostik P: Thymic epithelial tumors can develop along two different pathogenetic pathways. Am J Pathol 2001, 159:1853-1860
11. Theile M, Seitz S, Arnold W, Jandrig B, Frege R, Schlag PM, Haensch W, Guski H, Winzer KJ, Barrett JC, Scherneck S: A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene 1996, 13:677-685
12. Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D: Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 1998, 58:2170-2175
13. Reutzel D, Mende M, Naumann S, Störkel S, Brenner W, Zabel B, Decker J: Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization. Cytogenet Cell Genet 201, 93:221-227
14. Jin C, Martins C, Jin Y, Wiegant J, Wennerberg J, Dictor M, Gisselsson D, Strömbeck B, Fonseca I, Mitelman F, Tanke HJ, Hoglund M, Mertens F: Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA-FISH. Genes Chromosom Cancer 2001, 30:161-167
15. Wan M, Sun T, Vyas R, Zheng J, Granada E, Dubeau L: Suppression of tumorigenicity in human ovarian cancer cell lines is controlled by a 2 cM fragment in chromosomal region 6q24-q25. Oncogene 1999, 18:1545-1551
16. Jackson A, Carrara P, Duke V, Sinclair P, Papaioannou M, Harrison CJ, Foroni L: Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis. Cancer Res 2000, 60:2775-2779
17. Offit K, Parsa NZ, Gaidano G, Filippa DA, Louie D, Pan D, Jhanwar SC, Dalla-Favera R, Chaganti RSK: 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 1993, 82:2157-2162
18. Starostik P, Greiner A, Schultz A, Zettl A, Peters K, Rosenwald A, Kolve M, Müller-Hermelink HK: Genetic aberrations common in gastric high-grade large B-cell lymphoma. Blood 2000, 95:1180-1187
19. Rosai J, Sobin LH: Histological typing of tumors of the thymus. WHO International Histological Classification of Tumors. Edited by J Rosai, LH Sobin Berlin, Springer Verlag, 1999, pp 1-65
20. Müller-Hermelink HK, Marx A: Pathological aspects of malignant and benign thymic disorders. Ann Med 1999, 31(Suppl 2):5-14
21. Masaoka A, Monden Y, Nakahara K, Tanioka T: Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981, 48:2485-2492
22. Sambrook J, Frisch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Press, 1989
23. Utada Y, Haga S, Kajiwara T, Kasumi F, Sakamoto G, Nakamura Y, Emi M: Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3. J Cancer Res 2000, 91:293-300
24. Wang VW, Bell DA, Berkowitz RS, Mok SC: Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosome 5 and 6 in microdissected early-stage ovarian tumors. Cancer Res 2001, 61:4169-4174
25. Druey KM: Bridging with GAPs: receptor communication through RGS proteins. Sci STKE 2001, 104:RE14
26. Honchel R, McDonnell S, Schaid DJ, Thibodeau SN: Tumor necrosis factor-α allelic frequency and chromosome 6 allelic imbalance in patients with colorectal cancer. Cancer Res 1996, 56:145-149
27. Feenstra M, Veltkamp M, van Kuik J, Wiertsema S, Slootweg P, van den Tweel J, de Weger R, Tilanus M: HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas. Tissue Antigens 1999, 54:235-245
28. Koopman LA, Corver WE, van der Slik AR, Giphart MJ, Fleuren GJ: Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J Exp Med 2000, 191:961-975
29. Bevan S, Catovsky D, Matutes E, Antunovic P, Auger MJ, Ben-Bassat I, Bell A, Berrebi A, Gaminara EJ, Junior ME, Mauro FR, Quabeck K, Rassam SMB, Reid C, Ribeiro I, Stark P, van Dongen JJM, Wimperis J, Wright S, Marossy A, Yuille MR, Houlston RS: Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia. Blood 2000, 96:3982-3984
30. Saitoh Y, Bruner JM, Levin VA, Kyritsis AP: Identification of allelic loss on chromosome arm 6p in human astrocytomas by arbitrarily primed polymerase chain reaction. Genes Chromosom Cancer 1998, 22:165-170
31. Willcox N, Schluep M, Ritter MA, Schuurman HJ, Newsom-Davis J, Christensson B: Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset? Am J Pathol 1987, 127:447-460
32. Ashton-Rickardt PG, Tonegawa S: A differential-avidity model for T-cell selection. Immunol Today 1994, 15:362-366
33. Jameson SC, Hogquist KA, Bevan MJ: Positive selection of thymocytes. Annu Rev Immunol 1995, 13:93-126
34. Fukui Y, Ishimoto T, Utsuyama M, Gyotoku T, Koga T, Nakao K, Hirokawa K, Katsuki M, Sasazuki T: Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus. Immunity 1997, 6:401-410
35. Barton GM, Rudensky AY: Requirement for diverse, low-abundance peptides in positive selection of T cells. Science 1999, 283:67-70
36. Inoue M, Fujii Y, Okumura M, Takeuchi Y, Shiono H, Miyoshi S, Matsuda H, Shirakura R: Neoplastic thymic epithelial cells of human thymoma support T cell development from CD4-CD8- cells to CD4+CD8+ cells in vitro. Clin Exp lmmunol 1998, 112:419-426
37. Inoue M, Okumura M, Miyoshi S, Shiono H, Fukuhara K, Kadota Y, Shirakura R, Matsuda H: Impaired expression of MHC class II molecules in response to interferon-gamma (IFN-γ) on human thymoma neoplastic epithelial cells. Clin Exp Immunol 1999, 117:1-7
38. Müller-Hermelink HK, Wilisch A, Schultz A, Marx A: Characterization of the human thymic microenvironment: lymphoepithelial interaction in normal thymus and thymoma. Arch Histol Cytol 1997, 60:9-28
39. Kadota Y, Okumura M, Miyoshi S, Kitagawa-Sakakida S, Inoue M, Shiono H, Maeda Y, Kinoshita T, Shirakura R, Matsuda H: Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-γ). Clin Exp Immunol 2000, 121:59-68
40. Bell DW, Jhanwar SC, Testa JR: Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma. Cancer Res 1997, 57:4057-4062
41. Menasce LP, Orphanos V, Santibanez-Koref M, Boyle JM, Harrison CJ: Common region of deletion on the long arm of chromosome 6 in non-Hodgkin's lymphoma and acute lymphoblastic leukaemia. Genes Chromosom Cancer 1994, 10:286-288
42. Noviello C, Courjal F, Theillet C: Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion. Clin Cancer Res 1996, 2:1601-1606
43. Jackson A, Panayiotidis P, Foroni L: The human homologue of the Drosophila tailless gene (TLX): characterization and mapping to a region of common deletion in human lymphoid leukemia on chromosome 6q21. Genomics 1998, 50:34-43
44. Okumura M, Miyoshi S, Fujii Y, Takeuchi Y, Shiono H, Inoue M, Fukuhara K, Kadota Y, Tateyama H, Eimoto T, Matsuda H: Clinical and functional significance of WHO classification on human thymic epithelial neoplasms. A study of 146 consecutive tumors. Am J Surg Pathol 2001, 25:103-110